Tom ntej no -Tim Nkij teb chaws Biopurification Technology: Txoj Cai Tseem Ceeb, Cov Cwj Pwm Tseem Ceeb, Thiab Kev Siv Khoom Siv Ntawm Membrane Chromatography

I. Membrane Chromatography yog dab tsi?

Membrane chromatography siv cov ntxeem tau sib cais raws li qhov nruab nrab chromatographic, nrog rau cov ligands immobilized ntawm daim nyias nyias. Los ntawm kev cia siab rau kev sib hloov-dominated loj hloov pauv ntau dua li qhov diffusion- txwv tsis pub hloov pauv ntau ntawm cov khoom siv ib txwm siv-raws li chromatography, nws ua rau cov nqi ntws siab, siab daws teeb meem, yooj yim scalability, tsis tshua muaj siab poob, thiab ib zaug - siv bioprocessing rau kev ua kom huv ntawm biomolecules.

Cov ntsiab lus tseem ceeb: Membrane chromatography yog cov cuab yeej ua kom huv huv tau zoo raws li kev sib hloov - dominated mass transfer.

 

 

II. Qhov sib txawv ntawm Membrane Chromatography thiab Resin-Raws li Packed-Bed Chromatography

Qhov Tseem Ceeb Sib Txawv hauv Kev Hloov Loj

• Resin-raws li packed- txaj chromatography: Cov pores nyob rau hauv resin particles tuag- kawg pores, ua rau qeeb heev diffusion ntawm loj molecules. Raws li tus nqi ntws nce, ob qho tib si daws teeb meem thiab kev khi peev xwm txo qis heev.
• Membrane chromatography: Cov membrane pores feem ntau yog dhau los ntawm - qhov pores, tso cai rau cov kua dej xa ncaj qha los ntawm convection mus rau qhov chaw khi ntawm phab ntsa pore. Yog li ntawd, tus nqi ntws muaj me ntsis cuam tshuam rau kev daws teeb meem thiab kev sib khi muaj peev xwm.

 

 

 

III. Kev tsim kho tshiab hauv Membrane Chromatography: Peb -Txoj kev tawg ntawm cov khoom, cov qauv, thiab cov txheej txheem

1. Kev tsim kho tshiab hauv Membrane Materials (Matrix + Ligand + Coupling)

Matrix:

• Ntuj: cellulose, polysaccharides.
• Synthetic: Nylon, PES, PTFE.
• Novel: nanofibers, agarose fibers (siab tshwj xeeb thaj chaw).

Ligands:

• Ion txauv (feem ntau mature): quaternary ammonium pawg (AEX), sulfonic acid pawg (CEX).
• Affinity: Protein A/G, peptide ligands, hlau chelation (IDA), dyes, aptamers.
• Hydrophobic: phenyl, alkyl pawg.

Coupling Technologies:Rau membrane matrices nrog reactive chaw ntawm daim nyias nyias:

Ua ntej-synthesized ligands tuaj yeem txuas ncaj qha rau ntawm daim nyias nyias.

Polymerization tuaj yeem pib ncaj qha rau ntawm daim nyias nyias. Piv txwv li, cation- pauv daim nyias nyias thiab sib xyaw- hom chromatography daim nyias nyias tuaj yeem npaj siv atom hloov pauv radical polymerization (ATRP). Txoj kev sib txuas no tuaj yeem ua rau muaj peev xwm sib txuas tau zoo.

Rau daim nyias nyias matrices tsis muaj qhov chaw reactive ntawm daim nyias nyias, cov txheej txheem tsim kom muaj peev xwm siv tau los qhia qhov chaw reactive. Piv txwv li, dopamine-coated membrane matrix tuaj yeem hnov ​​​​mob nrog thiol- thiab amino- muaj ligands los ntawm Michael ntxiv thiab Schiff puag cov tshuaj tiv thaiv.

Spacer Arms:
Kev nthuav qhia cov caj npab spacer nruab nrab ntawm daim nyias nyias matrix thiab ligands tuaj yeem txhim kho kev nkag tau ntawm lub hom phiaj molecules rau ligands. Qhov tsim nyog spacer caj npab tuaj yeem nce ligand ceev thiab txhim kho ligand siv efficiency thaum lub sij hawm sib cais.

 

 

2. Innovations nyob rau hauv Module Design (Peb Lub Ntsiab Teeb Meem + Novel Designs)

• Stacked Disc Hom (Lab Khoom Khoom):Cov nplooj ntawv membrane tau muab tso ua ke, tsim cov qauv zoo ib yam li cov kab luv luv. Nws yooj yim los ntsuas, tab sis qhov ntws - teb faib tsis sib xws.

• Radial Flow Hom (Mainstream Industrial Tsim):Lub membrane yog mob nyob ib ncig ntawm lub hauv nruab nrab kem. Nws tsim nyog rau kev khiav - los ntawm cov ntawv thov (kev tshem tawm impurity), tab sis tsis haum rau khi- thiab - elute daim ntawv thov.

 

 

3. Kev ua kom zoo tshaj plaws (Kev ua haujlwm tas mus li + Kev Tshaj Tawm Siab + Kev Ua Haujlwm Txawj Ntse)

• Hom kev ua haujlwm:Flow-los ntawm (kev tshem tawm impurity) thiab khi-thiab-elute (lub hom phiaj ntes).
• Nruam Chromatography:Ntau -kem nruam chromatography technologies, xws li simulated txav txaj (SMB) thiab lub sij hawm counter-tam sim no (PCC) chromatography, tuaj yeem ua kom cov khoom tsim tau thaum txo qis kev noj zaub mov.
• High-Kev tshuaj ntsuam xyuas:Miniaturized membrane modules nrog tus nqi ntws siab ua kom sai, siab -throughput optimization (piv txwv li, 96-zoo phaj daim nyias nyias chromatography) ntawm cov tsis xws li pH thiab ntsev concentration thaum txo cov qauv noj.

 

• IV. Daim Ntawv Thov Kev Pom Zoo: Kev tsom mus rau Macromolecules thiab Tom ntej no -Tsim Biologics
• Membrane chromatography yog maj mam hloov qee cov resin-raws li chromatography cov kauj ruam hauv cov txheej txheem ua kom muaj protein ntau, xws li monoclonal antibodies thiab fusion proteins. Nws kuj tseem muaj qhov tshwj xeeb zoo hauv kev ua kom huv ntawm tom ntej - tiam biopharmaceuticals:
• Macromolecular Proteins:Monoclonal antibodies (150 kDa), PEGylated proteins (molecular size ×10), and SARS-CoV-2 spike proteins (multimeric). High flow rates thiab high yields ua membrane chromatography zoo suited rau downstream txheej txheem intensification.

 

 

• Nucleic Acids:Plasmid DNA thiab mRNA (membrane chromatography muaj peev xwm khi ntau dua li cov resin-raws li chromatography).
• Kab mob thiab kab mob -Zoo li cov kab (VLPs):Influenza virus, AAV, and HIV-VLPs (loj particles of 200–400 nm). Diffusion los ntawm resin xov xwm yog qhov qeeb heev, thiab kev siv qhov pore tsawg tuaj yeem txo qhov muaj peev xwm ntawm kev khi. Membrane chromatography, los ntawm qhov sib txawv, ua kom muaj txiaj ntsig zoo ntawm kev hloov pauv huab cua, muaj qhov pore nkag tau yooj yim, cov nqi ntws siab, thiab muaj peev xwm khi tau siab.
• Extracellular Vesicles:Exosomes thiab microvesicles (50-1,000 nm loj). Cov khoom no tsis tuaj yeem nkag mus rau hauv lub qhov hws ntawm cov xov xwm cob qhia thiab cuam tshuam nrog cov ligands, ua rau daim nyias nyias chromatography ib qho tsim nyog purification technology.

 

 

V. Kev Sib Tw thiab Outlook: Sib npaug Scalability thiab Performance

1. Cov Ntsiab Lus Tseem Ceeb

• Low Binding Surface Area: Membranes yog tus kheej -cov qauv kev txhawb nqa, nrog rau qhov zoo ntawm qhov sib txuas ntawm thaj chaw qis dua li ntawm cov xov xwm resin. Qhov no tuaj yeem ua rau muaj peev xwm khi tsis txaus hauv khi - thiab - elute daim ntawv thov.
• Tus nqi siab: Ib qho - siv cov membrane modules kuj yuav kim heev, uas txwv tsis pub lawv cov khoom siv dav dav ntawm qhov loj, tshwj tsis yog cov khoom muaj txiaj ntsig siab.
• Commercial Module Limitations: Tsis yog- tsis tu ncua kev faib tawm thiab kev daws teeb meem tsis txaus tseem muaj teeb meem hauv cov khoom lag luam muaj, xav tau kev txhim kho ntxiv ntawm kev tsim qauv.
• Ligand Stability: Affinity ligands xws li Protein A raug rau qhov hnyav elution tej yam kev mob, tshwj xeeb tshaj yog acidic pH, uas tuaj yeem ua rau ligand degradation thiab lub neej ua haujlwm luv.

2. Cov lus qhia yav tom ntej

• Cov ntaub ntawv: Tsim cov membrane matrices nrog ntau dua binding muaj peev xwm, txhim khu kev ruaj ntseg, thiab tus nqi qis, xws li electrospun fibers thiab mix-matrix membranes. Tsim kom tsawg -nqi affinity ligands, nrog rau peptides thiab biomimetic ligands, raws li lwm txoj rau Protein A.
• Modules: Tsim cov kev tshawb fawb optimized module tsim nrog ntau yam txaus faib thiab ntau dua kev daws teeb meem. Modular designs featuring ib lub tsev ruaj ruaj nrog cov khoom siv hloov pauv tau tuaj yeem pab txo tus nqi ib qho kev siv.
• Cov txheej txheem: Txhawb kev ua haujlwm tas mus li thiab kev sib koom ua ke, xws li cov txheej txheem membrane-resin tandem. Ua kom muaj ntau yam - rov siv lub voj voog los ntawm kev txhim kho cov txheej txheem ntxuav thiab rov tsim dua tshiab kom txo tau cov nqi khiav haujlwm.
• Cov ntawv thov: nthuav dav siv cov membrane chromatography hauv cov teb tshiab xws li cov kab mob, VLPs, exosomes, thiab mRNA los tsim kom muaj kev sib txawv thiab nyuaj - los - hloov cov txiaj ntsig thev naus laus zis.

 

 

VI. Xaus

Nrog nws cov txiaj ntsig tseem ceeb ntawm kev hloov pauv huab cua, siab txaus, yooj yim scalability, thiab tsis tshua muaj siab poob, daim nyias nyias chromatography yog hloov zuj zus los ntawm "kev hloov pauv ntxiv" rau hauv cov thev naus laus zis hauv bioprocessing. Txawm hais tias cov kev sib tw tseem nyob rau hauv cov nqe lus ntawm kev khi lub peev xwm, tus nqi, thiab kev tsim qauv, nws tus nqi tshwj xeeb hauv kev ua kom huv ntawm macromolecules thiab tom ntej no - tiam biologics yuav txuas ntxiv tsav kev tsim kho tshiab hauv cov ntaub ntawv membrane, module configurations, thiab txheej txheem technologies.

Nyob rau hauv lub neej yav tom ntej, daim nyias nyias chromatography yuav tsum tau los ua ib tug tseem ceeb technology rau downstream biopharmaceutical purification, nrog tshwj xeeb muaj peev xwm tseem ceeb nyob rau hauv tas li ntawd lawm manufacturing thiab tawm tshiab biotherapeutic daim ntaub ntawv.